[Combination effect of teicoplanin and panipenem on highly resistant strains of MRSA].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 10367264)

Published in Jpn J Antibiot on March 01, 1999

Authors

Y Utsui1, C Ishii, T Abe, M Kakuta, S Ohya

Author Affiliations

1: Biological Research Laboratories, SANKYO CO., LTD., Tokyo, Japan.

Articles by these authors

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell (1999) 7.56

The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med (1993) 6.37

Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1992) 4.74

Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 3.98

Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2000) 3.78

Application of typing by pulsed-field gel electrophoresis to the study of Clostridium difficile in a neonatal intensive care unit. J Clin Microbiol (1994) 3.51

Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J Neurosci (1997) 3.49

Artificial surfactant therapy in hyaline-membrane disease. Lancet (1980) 3.21

Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol (1994) 2.74

Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2000) 2.67

Analysis of codon usage diversity of bacterial genes with a self-organizing map (SOM): characterization of horizontally transferred genes with emphasis on the E. coli O157 genome. Gene (2001) 2.55

Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1996) 2.18

Muscle-fiber pennation angles are greater in hypertrophied than in normal muscles. J Appl Physiol (1985) (1993) 2.01

K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. Am J Physiol Heart Circ Physiol (2005) 1.89

Endoscopic ultrasound examination for mediastinal lymph node metastases of lung cancer. Chest (1990) 1.85

Bisulfite sequencing and dinucleotide content analysis of 15 imprinted mouse differentially methylated regions (DMRs): paternally methylated DMRs contain less CpGs than maternally methylated DMRs. Cytogenet Genome Res (2006) 1.84

Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines. Leukemia (1997) 1.83

Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer (2001) 1.77

Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity. Br J Pharmacol (2007) 1.75

Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma. Cancer Res (1991) 1.71

Identification and characterization of SEB, a novel protein that binds to the acute undifferentiated leukemia-associated protein SET. Eur J Biochem (2001) 1.68

Structure and regulation of rat long-chain acyl-CoA synthetase. J Biol Chem (1990) 1.68

Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer (1999) 1.68

Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer (2000) 1.67

Pharmacological evidence for the persistent activation of ATP-sensitive K+ channels in early phase of reperfusion and its protective role against myocardial stunning. Circulation (1995) 1.67

A eukaryotic gene encoding an endonuclease that specifically repairs DNA damaged by ultraviolet light. EMBO J (1995) 1.63

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial. Br J Cancer (2003) 1.63

Cholesterol granuloma in the petrous apex: case report and review. Acta Neurochir (Wien) (2001) 1.61

Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid media. Antimicrob Agents Chemother (1991) 1.61

Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat Biotechnol (2001) 1.57

Extensive lymphopenia due to apoptosis of uninfected lymphocytes in acute measles patients. Arch Virol (2000) 1.55

SNARE complex oligomerization by synaphin/complexin is essential for synaptic vesicle exocytosis. Cell (2001) 1.53

A severe outbreak of haemorrhagic colitis and haemolytic uraemic syndrome associated with Escherichia coli O157:H7 in Japan. Eur J Pediatr (1994) 1.52

Determination of optimum retrograde cerebral perfusion conditions. J Thorac Cardiovasc Surg (1994) 1.51

Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society. Blood (1999) 1.51

Biochemical characterization and expression analysis of neural thrombospondin-1-like proteins NELL1 and NELL2. Biochem Biophys Res Commun (1999) 1.50

Deficiency of glycosyl-phosphatidylinositol anchored proteins on paroxysmal nocturnal haemoglobinuria (PNH) neutrophils and monocytes: heterogeneous deficiency of decay-accelerating factor (DAF) and CD16 on PNH neutrophils. Br J Haematol (1990) 1.49

Polymerization and depolymerization of microtubules in vitro as studied by flow birefringence. FEBS Lett (1974) 1.48

Fat-free mass is related to one-mile race performance in elite standardbred horses. Vet J (2002) 1.48

Cardiopulmonary bypass and cellular immunity: changes in lymphocyte subsets and natural killer cell activity. Ann Thorac Surg (1993) 1.47

Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes. J Immunol (1982) 1.47

Interplay between chromosomal beta-lactamase and the MexAB-OprM efflux system in intrinsic resistance to beta-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1999) 1.46

Overview of horse body composition and muscle architecture: implications for performance. Vet J (2002) 1.46

Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease. J Clin Invest (1997) 1.45

Suspected rotavirus encephalitis. Arch Dis Child (1986) 1.45

Characterization of cardiac myocyte and tissue beta-adrenergic signal transduction in rats with heart failure. Cardiovasc Res (2001) 1.44

Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones. Antimicrob Agents Chemother (1995) 1.44

Clinical significance of elevated soluble interleukin-6 receptor levels in the sera of patients with plasma cell dyscrasias. Br J Haematol (1995) 1.43

Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am J Respir Crit Care Med (1997) 1.43

Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer (2000) 1.43

Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother (1996) 1.42

Infantile leukemia and soybeans--a hypothesis. Leukemia (1999) 1.42

Relationship between transcardiac gradient of endothelin-1 and left ventricular remodelling in patients with first anterior myocardial infarction. Eur Heart J (2003) 1.41

Characteristics of anti-T-cell antibodies in systemic lupus erythematosus: evidence for selective reactivity with normal suppressor cells defined by monoclonal antibodies. Clin Immunol Immunopathol (1980) 1.41

Marginal benefit/disadvantage of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in children: results of a prospective randomized trial. The Japanese Cooperative Study Group of PBSCT. Blood (1998) 1.41

[Cerebrospinal fluid analysis in Kirisawa-Urayama type uveitis]. Nippon Ganka Gakkai Zasshi (1999) 1.40

Protective effects of dimethyl amiloride against postischemic myocardial dysfunction in rabbit hearts: phosphorus 31-nuclear magnetic resonance measurements of intracellular pH and cellular energy. J Thorac Cardiovasc Surg (1996) 1.39

Batista operation for dilated cardiomyopathy: a physiologic concept. J Thorac Cardiovasc Surg (1998) 1.39

New modification of a mammary artery retractor. Ann Thorac Surg (1994) 1.39

Mandibular ameloblastoma with metastasis to the lungs and lymph nodes: a case report and review of the literature. J Oral Maxillofac Surg (1989) 1.38

Long-term thrombosis after transvenous permanent pacemaker implantation. Pacing Clin Electrophysiol (1998) 1.38

New cephamycin antibiotic, CS-1170: binding affinity to penicillin-binding proteins and inhibition of peptidoglycan cross-linking reactions in Escherichia coli. Antimicrob Agents Chemother (1978) 1.37

Isolation and characterization of presynaptically acting neurotoxins from the venom of Bungarus snakes. Eur J Biochem (1977) 1.36

Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res (2000) 1.35

Local Ca(2+) transients and distribution of BK channels and ryanodine receptors in smooth muscle cells of guinea-pig vas deferens and urinary bladder. J Physiol (2001) 1.35

Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer (1997) 1.35

Synaphin: a protein associated with the docking/fusion complex in presynaptic terminals. Biochem Biophys Res Commun (1995) 1.34

Structure of the human ferrochelatase gene. Exon/intron gene organization and location of the gene to chromosome 18. Eur J Biochem (1992) 1.34

Rapid colorimetric assay for the quantification of leukemia inhibitory factor (LIF) and interleukin-6 (IL-6). J Immunol Methods (1991) 1.33

Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes. J Pharmacol Exp Ther (2001) 1.32

Selective effector mechanisms for the expulsion of intestinal helminths. Parasite Immunol (1994) 1.32

Japanese society of neuro-endovascular treatment specialist qualification system. Six years' experience and introduction of an animal model examination. Interv Neuroradiol (2008) 1.31

Training-induced changes in muscle architecture and specific tension. Eur J Appl Physiol Occup Physiol (1995) 1.30

Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res (1996) 1.28

Repair of double-chambered right ventricle: surgical results and long-term follow-up. Ann Thorac Surg (2001) 1.28

Association between HLA and Japanese patients with rheumatoid arthritis. Hum Immunol (1982) 1.28

Evidence for positional differentiation of prestalk cells and for a morphogenetic gradient in Dictyostelium. Cell (1995) 1.28

Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model. J Immunother (2001) 1.28

Sprint performance is related to muscle fascicle length in male 100-m sprinters. J Appl Physiol (1985) (2000) 1.27

Antibacterial halogenated metabolites from the Malaysian Laurencia species. Phytochemistry (2001) 1.26

Penicillin-binding proteins in Proteus species. J Bacteriol (1979) 1.26

Long-term follow-up study of unruptured intracranial aneurysms. Neurosurgery (1997) 1.25

Successful surgical treatment of giant coronary artery aneurysm with fistula. Ann Thorac Surg (2000) 1.24

Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation. Leukemia (2001) 1.24

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol Immunother (2001) 1.23

A model to simulate the haemodynamic effects of right heart pulsatile flow after modified Fontan procedure. Br Heart J (1992) 1.22

Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors. Hum Mol Genet (1996) 1.21

In vitro TNP-specific antibody formation by peripheral lymphocytes from patients with systemic lupus erythematosus. Scand J Immunol (1977) 1.21

Major basic protein binding to thrombomodulin potentially contributes to the thrombosis in patients with eosinophilia. Br J Haematol (1995) 1.19

Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn J Cancer Res (1991) 1.19

Ion implantation and protein coating of detachable coils for endovascular treatment of cerebral aneurysms: concepts and preliminary results in swine models. Neurosurgery (1997) 1.19

Does the Adamkiewicz artery originate from the larger segmental arteries? J Thorac Cardiovasc Surg (1999) 1.18

Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1986) 1.18

CT and MR imaging of acute cerebellar ataxia. Neuroradiology (1991) 1.18

Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms. Cancer Biol Ther (2005) 1.18

Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab. Rheumatology (Oxford) (2008) 1.17

A follow-up study by CT and MRI in 3 cases of Japanese encephalitis. Neuroradiology (1990) 1.17

Isolation and structure of dynorphin, an opioid peptide, from porcine duodenum. Nature (1982) 1.16